Webb14 juli 2024 · July 14, 2024 - In May 2024, Phlow Corp. received $354 million to bring inexpensive generic pharmaceutical manufacturing to the United States. At the time, it … WebbBARDA is making critical investments to accelerate the expansion of domestic manufacturing capacity for ancillary supplies (e.g., needles, syringes, vials) as part of our …
BARDA Funding Tracker - Public Citizen
Webb20 maj 2024 · The agency’s BARDA has closed a four-year, $354 million deal with Phlow Corp. to manufacture medicines needed during the pandemic and future public health emergencies. Manufacturing … Webb19 maj 2024 · RICHMOND, Va., May 19, 2024 /PRNewswire/ -- Phlow, a U.S.-based, public benefit drug manufacturing corporation, has received federal government funding of $354 million for advanced manufacturing of America's most essential medicines at risk of shortage, including medicines for the COVID-19 pandemic response. how to check cpu in linux command
BRIEF-Phlow Corp Awarded $354 Million HHS/ASPR/BARDA …
Webb9 mars 2024 · Using federal emergency dollars, the Trump administration awarded Phlow an initial $354 million, four-year contract in May 2024, with an option for $458 million more and an increase to 10 years. Webb16 juli 2024 · The Biomedical Advanced Research and Development Authority (BARDA), which is a part of the HHS, is providing the funds via an initial four-year award of $354M, … Webb9 juni 2024 · At Phlow Corp., we are continuously working to solve the broken essential medicine supply chain which has led to critical drug shortages. We offer a resilient end-to-end solution that is U.S.- based, comprehensive, and fully integrated. michigan business tax filing requirements